← All trials
NCT02057198
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 10, 2014
- Primary completion
- Jun 27, 2017
- Completion date
- Jun 27, 2017
- First posted
- Feb 6, 2014
- Last posted
- Oct 2, 2019
- Enrollment
- 33
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Duke UniversityLead sponsor
- Duke UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.